$27.51
+0 (+0%)
At Close: Jun 03, 2026
Hims & Hers Stock Dropped: Here's What You Need to Know
10:35am, Thursday, 24'th Oct 2024
The GLP-1 drama continues at Hims & Hers.
Hims & Hers Health Tops Growth 50 List As FDA OKs Cheaper Weight-Loss Drug
01:43pm, Monday, 21'st Oct 2024
Hims stock is near its all time high and a buy point of 25.74.
Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers
09:00am, Monday, 21'st Oct 2024
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced Dr. Jessica Shepherd is joining as the first Chief M
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock
10:05am, Friday, 18'th Oct 2024
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why Hims & Hers' Incredible Growth Will Continue
05:08am, Friday, 18'th Oct 2024
GLP-1s get all the attention, but Hims & Hers' core business is where the rocket growth is.
HIMS: GLP-1 Is Just The Beginning
11:14am, Thursday, 17'th Oct 2024
Hims & Hers is revolutionizing healthcare with affordable, convenient telehealth services, leading to a 260% stock increase in the last year. The company benefits from GLP-1 drug sales and is position
Hims & Hers Stock Jumps as FDA Reconsiders Restrictions on Copycat Weight-Loss Drugs
04:40pm, Monday, 14'th Oct 2024
Hims & Hers Health (HIMS) shares surged Monday after the Food and Drug Administration (FDA) said compounding pharmacies could continue to produce copycat weight-loss drugs while it reconsiders whether
Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024
04:05pm, Monday, 14'th Oct 2024
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced that it will report third quarter financial results afte
Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug
12:29pm, Monday, 14'th Oct 2024
Hims stock popped Monday after the FDA reportedly said it would reconsider its decision to bar compounders from selling knockoff tirzepatide.
FDA Buzz Sends Health and Wellness Stock Surging
11:03am, Monday, 14'th Oct 2024
Shares of Hims & Hers Health Inc (NYSE:HIMS) are popping 10% higher to trade at $20.50 this morning, running higher off good news from the Food and Drug Administration (FDA).
Where Does Hims & Hers Stock Go From Here?
08:15am, Saturday, 12'th Oct 2024
Is Hims & Hers in trouble since the FDA put a time clock on some GLP-1s, or is the future still bright?
2 Incredibly Cheap Growth Stocks to Buy Right Now
07:30am, Saturday, 12'th Oct 2024
Look beyond the stock price at the business when shares are volatile.
2 No-Brainer Growth Stocks to Buy With $500 Right Now
05:55am, Saturday, 12'th Oct 2024
Consistently investing even moderate sums can grow your portfolio with time.
What Is Going On With Hims & Hers Stock?
10:23am, Friday, 11'th Oct 2024
Big GLP-1 news could have an impact.
Top 3 Stocks with Explosive Call Option Activity: What to Watch
08:32am, Thursday, 10'th Oct 2024
When considering a long position in a stock, investors usually consider buying shares in a company to express their views. However, they need to realize that there is a much more aggressive way to gai
Sign In
Buy HIMS